Cytokinetics's total assets for Q3 2024 were $1.44B, a decrease of -5.76% from the previous quarter. CYTK total liabilities were $1.45B for the fiscal quarter, a 2.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.